Advertisement

Topics

FDA Grants Fast Track Designation to Sanaria's Malaria Vaccine

11:00 EDT 23 Sep 2016 | Drug Discovery Development

Sanaria PfSPZ Vaccine is in clinical trials in subjects ranging in age from 6-month old infants to adults in the U.S., Europe and Africa.
Topics: 

Original Article: FDA Grants Fast Track Designation to Sanaria's Malaria Vaccine

NEXT ARTICLE

More From BioPortfolio on "FDA Grants Fast Track Designation to Sanaria's Malaria Vaccine"

Quick Search
Advertisement
 

Relevant Topic

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...